K BIO Health

What K BIO Health does

K BIO Health (legal name: 오송첨단의료산업진흥재단, Osong Advanced Medical Industry Promotion Foundation) is a Korean public foundation established in 2010 and headquartered in the Osong Advanced Medical Industry Complex in Cheongju-si, Chungcheongbuk-do, South Korea. Its mandate is to support the domestic bio/healthcare industry through research activation and commercialization, positioning the foundation as a central hub that ranks among the top 10 in Korea's bio/healthcare industry by market standing.

The foundation delivers technical services through four specialized centers: the New Drug Development Support Center (190 services), Advanced Medical Device Development Support Center (146 services), Preclinical Support Center (30 services), and Biopharmaceutical Production Center (42 services) — totaling 408 distinct technical services and supported by digital platforms including the Technical Service Integrated System (기술서비스 통합시스템), KROSS project management system, IACUC system, and Smart Specialization Platform. Its Advanced Medical Device Development Support Center holds KOLAS accreditation, MFDS designation as a medical device testing and preclinical trial institution, and GLP compliance; the foundation also holds ISO 45001 certification. Cumulative track record includes 11,500 technical services delivered, 388 patents and technology transfers completed, and 2,597 professional personnel trained.

As a public foundation, KBIOHealth operates a non-profit, government-funded model, receiving project-based support from multiple Korean ministries (Ministry of Science and ICT, Ministry of Trade/Industry/Energy, Ministry of Health and Welfare, MFDS, KDCA, KHIDI, KOHI). Active national programs include a 198억 KRW (~USD 14M) Academic-Industry New Drug Development Project (2022-2027) and a 276억 KRW (~USD 20M) Bio Cluster Core Technology Construction Project (2026). Services are delivered to three primary segments — bio ventures and startups, academic-research institutions, and mid-to-large bio/pharma companies — with named customers including Alteogen, Cellico, Rznomics, Prestige Bio, Solmedix, G2G Bio, Intekmedi, and Onetech. International expansion is anchored by a strategic partnership with Japan's Shonan iPark, which supports Korean bio companies' entry into the Japanese market.

Name

K BIO Health

Legal name

오송첨단의료산업진흥재단

Website

https://kbiohealth.kr

Company type

Private

Founded year

2010

Operating status

Operating

Short description

Korean public foundation operating four specialized bio/healthcare R&D support centers — new drug development, medical devices, preclinical, and biopharma production — providing 408 technical services to startups, SMEs, and academic institutions from the Osong Medical Industry Complex.

Ownership category

akta.pro rank

Product category

Bio-pharmaceutical R&D Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

akta.pro secondary industries

Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Manufacturing, MSAT & Operations Staffing (API/Biologics/Cell & Gene) (HLAGAOAL), Life Sciences & Biotech (R&D/Clinical) Staffing (BPACADAL)

Keywords

• Bio-pharmaceutical R&D services
• Medical device testing
• Preclinical trial services
• Biopharmaceutical manufacturing
• Regulatory science consulting

Headquarters

HQ city

Chungbuk

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Distribution channels3 records

Marketing channels6 records

Core offering

K BIO Health (Osong Advanced Medical Industry Promotion Foundation) operates as a public bio-health R&D support institution providing 408 technical services across four specialized support centers: New Drug Development Support, Advanced Medical Device Development Support, Preclinical (GLP) Support, and Biopharmaceutical Production. Services span the full product lifecycle from bio-medicine optimization, efficacy evaluation, medical device prototype fabrication, GMP technical support, non-clinical safety/efficacy testing, and biopharmaceutical production/analytical method development, targeted at Korean bio ventures, startups, academic institutions, and mid-to-large bio/pharma companies.

Product overview

KBIOHealth operates as a public bio-health research and development support institution offering a portfolio of specialized service centers and platforms. The core service centers include New Drug Development Support (190 services), Advanced Medical Device Development Support (146 services), Preclinical Support (30 services), and Biopharmaceutical Production (42 services) — totaling 408 technical services. These are complemented by the Regulatory Science Support Unit (operational since 2021), professional human resources education programs, and the Innolabs innovation facility. Digital platforms supporting these services include the Technical Service Integrated System, KROSS project management system, IACUC system, and Smart Specialization Platform. The organization focuses on supporting biotech companies, startups, and research institutions throughout the product lifecycle from R&D to commercialization, particularly in the Osong Medical Industry Complex.

Differentiator

Problem solved

Functional benefit

Brands

• 이노랩스 (Innolabs): Innovation laboratory facility providing shared workspace and support for bio startups
• 규제과학지원단
• 첨단의료기기개발지원센터
• KROSS

Products and services

• New Drug Development Support Center (신약개발지원센터) Provides technology support services for new drug research, including bio-medicine optimization, efficacy evaluation, and process development. Offers 190 types of technical services for biotech and pharmaceutical companies developing new drugs.
• Advanced Medical Device Development Support Center (첨단의료기기개발지원센터) Supports medical device R&D, prototype fabrication, GMP technical support, and testing evaluation services. Offers 146 types of technical services, including GLP-compliant non-clinical trial evaluation, and operates the Smart Specialization Platform. Designated institution by MFDS with KOLAS accreditation.
• Preclinical Support Center (비임상지원센터) Performs preclinical trials for new drugs and medical devices to evaluate safety and efficacy. Offers 30 types of technical services with IACUC (Institutional Animal Care and Use Committee) oversight. Designated as a non-clinical trial institution by MFDS.
• Biopharmaceutical Production Center (바이오의약생산센터) Supports biopharmaceutical production, analytical method development and analysis, and promotes growth of the bio-industry. Offers 42 types of technical services covering biopharmaceutical manufacturing and quality analysis.
• Regulatory Science Support Unit (규제과학지원단) Provides regulatory consulting and pre-market approval support for biopharmaceuticals and medical devices. Offers infrastructure linked with regulatory consulting for integrated support, helping companies navigate complex authorization processes including global approvals.
• Professional Human Resources Development Program (전문인력양성) Provides education programs for training specialized personnel in the bio-pharmaceutical and medical device industries. Has trained 2,597 professionals in total. Operates in partnership with Korea Bio Human Resources Development Center.
• Innolabs (이노랩스) Innovation labs facility offering meeting rooms and support programs for bio startups and small/medium enterprises in the Osong Bio Cluster. Provides shared workspace and bio-startup support environment.

Quantifiable outcome

• 기술서비스 11,500건 제공
• +2 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• 과학기술정보통신부 (Ministry of Science and ICT)coreStrategic or Co-development Partner국가 정책 수립 및 연구개발사업 주관부처로서 협력
• 보건복지부 (Ministry of Health and Welfare)coreStrategic or Co-development Partner바이오헬스 산업 정책 및 인력개발 협력
• 산업통상자원부 (Ministry of Trade, Industry and Energy)coreStrategic or Co-development Partner산업 경쟁력 강화 및 바이오 산업 수출 지원 협력
• 식품의약품안전처 (MFDS)coreStrategic or Co-development Partner규제과학 및 인허가 지원 협력
• 질병관리청 (KDCA)coreStrategic or Co-development Partner감염병 연구 및 바이오 안전성 협력
• 한국보건산업진흥원 (KHIDI)coreStrategic or Co-development Partner보건산업 진흥 및 시장 확대 협력
• 한국보건복지인재원 (KOHI)minorStrategic or Co-development Partner바이오 전문 인력 양성 협력
• 쇼난아이팩 (Shonan iPark / iPark Institute)coreGTM or Marketing Partner일본 시장 진출 지원 위한 컨설팅 파트너, 3년 연속 공동 참가 (인터비즈 등)
• 충북대학교병원coreStrategic or Co-development Partner스마트특성화플랫폼 기반구축사업 협력기관
• 한국화학융합시험研究院 (KCTC)minorStrategic or Co-development Partner스마트특성화플랫폼 기반구축사업 협력기관

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• A*STAR (Agency for Science, Technology and Research): Singapore's lead public sector R&D agency providing biomedical sciences infrastructure, contract research, and biotech incubation. Highly comparable international peer with same public-mission bio-support model.
• KRIBB (Korea Research Institute of Bioscience and Biotechnology): Government-funded Korean bio-research institute providing R&D infrastructure, contract research, and bio-support services to Korean biotechs. Highly comparable as a public-sector peer with overlapping mission around biotech commercialization support.
• Shonan iPark (iPark Institute): Japan's leading bio-incubation and open-innovation campus operated as a public-private partnership. Direct partner of KBIOHealth for Japan market entry and highly comparable as a public-mission bio-support platform serving startups.

Broad incumbents

• KHIDI (Korea Health Industry Development Institute): Government-affiliated Korean health industry promotion agency providing policy support, market expansion, and industry development programs. Direct strategic partner of KBIOHealth and comparable as a public health industry support entity.
• KIST (Korea Institute of Science and Technology): Major Korean government research institute offering R&D services, technology transfer, and scientific staffing across multiple disciplines including bio/health. Comparable as a public-sector scientific infrastructure provider, though broader in scope than KBIOHealth.
• Samsung Biologics: Korea's largest CDMO providing biopharmaceutical manufacturing, analytical services, and regulatory support. Competes with KBIOHealth's biopharma production and preclinical services, but at much greater scale and with private-sector capital.
• WuXi AppTec: Global CRO/CDMO offering preclinical, clinical, and biologics manufacturing services. Comparable service portfolio to KBIOHealth, though at vastly larger scale and with private-sector capital.
• Charles River Laboratories: Global CRO providing preclinical, discovery, and manufacturing support services. Competes with KBIOHealth's preclinical and biopharma production services at global scale, but is private-sector and globally diversified.

Emerging players

• Osong Medical Innovation Foundation / KBIO Holdings entities: Adjacent Osong-based bio-support entities within the Osong Bio Medical Complex. Co-located ecosystem participants sharing the same biotech cluster and partly overlapping service portfolios with KBIOHealth.

Regional players

• KoreaBIO (Korea Biotechnology Industry Organization): Korean bio industry association providing policy advocacy, networking, and industry support services. Adjacent peer in the Korean bio-support ecosystem, complementing rather than directly competing with KBIOHealth's technical service offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCSkHxKHBFVpQ7vnPTrv5-2A
• Facebookfacebook.com/kbiohealth
• Instagraminstagram.com/kbiohealth

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about K BIO Health